Unternehmen
Mineralys Therapeutics
Mineralys Therapeutics is a publicly traded, clinical-stage biotechnology company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Our initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that we are developing for cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease.
Mineralys is a fully remote company.
For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn.
Offene Stellen
144
jetzt online
Neu heute
131
letzte 24 Stunden
Weltweit remote
0
von überall
Abteilungen
11
stellen ein in
Keine passenden Stellen
Derzeit passen keine offenen Stellen bei Mineralys Therapeutics zu diesen Filtern.